Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome
about
Human CD57+ germinal center-T cells are the major helpers for GC-B cells and induce class switch recombinationHyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological featuresUpdate on the hyper immunoglobulin M syndromesAID and Apobec3G haphazard deamination and mutational diversityThree novel mutations reflect the variety of defects causing phenotypically diverse X-linked hyper-IgM syndrome.Common variable immunodeficiency: etiological and treatment issues.Novel mutation of the activation-induced cytidine deaminase gene in a Tajik family: special review on hyper-immunoglobulin M syndrome.LINE-1 retroelements complexed and inhibited by activation induced cytidine deaminase.Variation in base excision repair capacity.APOBEC deaminases-mutases with defensive roles for immunity.Primary immunodeficiency diseases in adulthood.The hyper IgM syndrome--an evolving story.Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects.A structural basis for the biochemical behavior of activation-induced deoxycytidine deaminase class-switch recombination-defective hyper-IgM-2 mutantsBiochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A.Molecular defects in T- and B-cell primary immunodeficiency diseases.Evaluation of molecular models for the affinity maturation of antibodies: roles of cytosine deamination by AID and DNA repairImmunity to microbes: lessons from primary immunodeficiencies.AID can restrict L1 retrotransposition suggesting a dual role in innate and adaptive immunityEnrichment of rare variants in population isolates: single AICDA mutation responsible for hyper-IgM syndrome type 2 in FinlandHyper IgM Syndrome: a Report from the USIDNET RegistryPrimary immunodeficiencies associated with DNA-repair disorders.The hyper IgM syndromes.First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients.[Clinical and immunological profile of 15 Moroccan patients with Hyper IgM syndrome].Primary immunodeficiency diseases: dissectors of the immune system.Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire.Expression of activation-induced cytidine deaminase gene in B lymphocytes of patients with common variable immunodeficiency.AID mutant analyses indicate requirement for class-switch-specific cofactors.Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.Normal ICOS, ICOSL and AID alleles in Danish patients with common variable immunodeficiency.Recurrent severe arthralgia.An imbalance of naive and memory/effector subsets and altered expression of CD38 on T lymphocytes in two girls with hyper-IgM syndrome.A Severe Anaphylactic Reaction Associated with IgM-Class Anti-Human IgG Antibodies in a Hyper-IgM Syndrome Type 2 Patient.AID expression during B-cell development: searching for answers.Measurement of peripheral B cell subpopulations in common variable immunodeficiency (CVID) using a whole blood method.Epigenomic Modifications Mediating Antibody Maturation.
P2860
Q21263136-051DE093-AADA-46D1-842F-C802EB4D597AQ28303338-ADDB0CB8-E2C9-4209-9B27-100F257A8B98Q28972255-610F4E24-EB11-4BC2-82BF-9773DAA88816Q30537745-E865BEA0-4CAF-4C19-9FA9-B9BE84FD63F3Q30540413-DEB412D0-0B63-4CB0-B651-7B5BADC5120BQ33621805-9BD02742-DB38-4482-9DE2-AFFD47735B08Q34300622-43368237-D6A1-43BB-AAC1-9E8533D4F717Q34469970-56F3E2F3-795E-4E82-8054-F2E1F62861F9Q35004482-31317057-2A35-4523-ADB9-7D8B1C9D4BB5Q35012747-63489E4D-408A-453A-A456-38E8706ED47BQ35823417-4EB5D000-BD7E-48EF-A4A3-402D700C4820Q35866664-010BF475-D480-420B-80CA-E5BB339F1584Q36015017-40459387-84C6-4ED7-BA9E-0F7C9F6FD4D3Q36201805-8846823B-303E-498C-A355-D7EC1CA27897Q36216511-A6F24AD1-A7F2-4031-8368-4F8A3616F7D2Q36302334-B65872A5-6F3F-4EF8-A555-AB4C72AB8A0FQ36389685-6A961A04-3A45-4CD7-A203-56B4E7CAB941Q36729350-1C0ED583-EADC-4828-A6F0-5BB5489BF7A4Q37149767-93088056-1784-4439-91FB-4295DAD49EB0Q37264882-60ECD3D0-BB98-4E7E-836F-C20C6C90EAEFQ37291824-8E171F9F-0208-4B79-AE9E-AAF0D0063E39Q37713997-E7CC60B6-789C-4AA8-8D19-BDD81A5ED5B0Q38116775-0444669C-9B14-4AA0-B002-DC7D2A6B6C40Q38928362-AC004087-C3F2-44FF-A1D7-C09C7D9777FFQ39330315-6AB6AD11-1632-4215-9E90-7BD49CED315BQ40130020-4C3B74EA-5384-41BA-AD8D-DAB2F8A54B5EQ40638236-E4E9600A-E8F8-43C1-ACF8-B35556AA22E8Q41505077-96196BFA-ADC4-4275-922C-F1D8E951C7A8Q41855727-FE2EA321-4443-4BA1-9580-01B26CD16B5AQ42798287-05652630-07A3-4902-88A6-019BE3AE3AD9Q45874408-97315046-2B89-4557-8DB5-99D7372D1153Q46552795-3723F60F-759D-40B4-B35A-6FB8C0BE71AEQ47696372-BC807188-F0EA-40F6-BE69-8D1D7FCA54EEQ47759500-87B7C565-1793-4569-A5BD-3A2A5ADF4755Q48096564-3A99DF07-89F2-4B4D-ACD5-54DF9E92FAE6Q51028081-C5BF8BE1-980E-4D48-A231-4183EE9D75B4Q51991577-3C239D01-F28B-4D0A-AD21-4C424A72C9E7Q55011560-AF5321A3-3CC9-44F5-8419-6BA7EB682DCC
P2860
Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome
@ast
Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome
@en
Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome
@nl
type
label
Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome
@ast
Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome
@en
Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome
@nl
prefLabel
Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome
@ast
Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome
@en
Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome
@nl
P2093
P50
P3181
P356
P1433
P1476
Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome
@en
P2093
M E Conley
P M Bédard
R H Buckley
Y Minegishi
P304
P3181
P356
10.1006/CLIM.2000.4956
P407
P577
2000-12-01T00:00:00Z